QIRN 3 Logo
  •  
  •  
  • Home
  • About Us
    • Accessibility
    • Annual Reports
    • Conditions for Coverage
      • FAQs
    • Governance
    • Medical Review Board
    • QIRN 3 Required Postables
    • Staff Directory
    • Treatment Locations
  • Data
    • EQRS
    • Data Collection
      • CMS-2728
      • CMS-2744
      • CMS-2746
      • FAQs
    • Data Reporting
      • Annual Reports
      • National Data
      • Zip Code Reports
  • Dialysis Providers
    • 5-Diamond Program
    • COVID-19
    • ESRD QIP
    • Goals and Recommendations
    • Involuntary Discharge
    • New Facilities
    • Patient and Family Engagement
      • Beyond Engagement (2018 - Current Archives)
      • Beyond Engagement 2020
      • En-GAGE (2014-2017 Archives)
      • Resources
    • Patient-Provider Conflict
    • Resources
    • Transplant Designee Hub
    • Vascular Access
  • Emergency Preparedness
    • How We Can Assist You
    • Report Facility Emergency Event
  • Ongoing Projects
    • Flu Vaccination Champions
    • QIA Newsletter
    • Reducing BSIs and LTCs
    • Home Dialysis QIA
    • Transplant QIA
    • Vocational Rehabilitation QIA
    • Beyond Engagement 2020
  • Patients and Families
    • COVID-19
    • Care Compare
    • End of Life Care
    • FAQs
    • Grievances
    • Medicare
    • Patient Advisory Committee
    • Patient Engagement Archives
      • Patient Education
        • Treatment Options
        • New Patient Materials
        • Nutrition
        • Patient Safety
        • Staying Active
        • Additional Resources
        • Life Changes
      • Patient-Focused LAN
    • Rights and Responsibilities
    • Vocational Rehabilitation
  • News
    • Newsletters
      • Archived Newsletters
  • Contact Us
    • Facility Reporting
    • Staff Directory
  • Newsletters
    • Archived Newsletters

2015 Recalls and Alerts



12/18/2015 - Baxter International, Inc. 
Baxter Initiates Voluntary Recall of Two Lots of IV Solutions due to Potential Presence of Particulate Matter

10/22/2015 - FDA Safety Alert: Kayexalate 
Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Requires Drug Interaction Studies

9/21/2015 - US Compounding, Inc.
US Compounding, Inc. Issues Voluntary Nationwide Recall of All Sterile Compounded Products

9/9/2015 - Medistat RX, LLC
FDA Announces Medistat RX’s Nationwide Voluntary Recall of Sterile Drug Products

8/27/2015 - Insulet Corporation
Insulet Corporation Issues Voluntary Recall of OmniPod® Insulin Management System

7/30/2015 - Baxter International, Inc.
Baxter Initiates Voluntary Nationwide Recall of One Lot of IV Solution Due to the Potential For Leaking Containers, Particulate Matter and Missing Port Protectors

7/17/2015 - Baxter International, Inc.
Baxter Initiates Voluntary Recall Of Two Lots Of IV Solutions Due To The Potential Presence Of Particulate Matter

4/10/2015 - Baxter International, Inc.
Baxter Initiates Voluntary Recall of Select Lots of IV Solutions Due to the Potential Presence of Particulate Matter

01/20/15 - Hospira, Inc.
Hospira Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection, USP, 250 mL Due to Particulate Matter
News \ 2015 Recalls and Alerts